Family Medicine Doctors in Weiser, ID Accepting Medicare
6 Family Medicine doctors found. Showing 1 - 6
 Dr. Bryan L Drake, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 E Liberty St, Weiser, ID 83672 Phone: 208-414-1124 Fax: 208-414-0947 |
Deland Ray Barr, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 683 E 3rd St, Weiser, ID 83672 Phone: 208-549-0211 Fax: 208-549-0104 |
Jordan V Blanchard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 E. Liberty, Weiser, ID 83672 Phone: 208-414-1124 Fax: 208-414-0947 |
 Dr. Suzanna Dyann Hubele, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 683 E 3rd St, Weiser, ID 83672 Phone: 208-549-0211 Fax: 208-549-0104 |
Lore Beth Wootton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 683 E 3rd St, Weiser, ID 83672 Phone: 208-549-0211 Fax: 208-549-0104 |
Dr. Bradley Wescott Terry, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 E Liberty St, Weiser, ID 83672 Phone: 208-549-4424 |
News Archive
FVCG portfolio companies selected to present research at Bio International 2015
Actinobac Biomed, NovoPedics, Inc. and MentiNova, Inc., three biotech start-up companies originally funded with investments from Foundation Venture Capital Group (FVCG), have been selected to present their research at Bio International 2015 as part of the Start-Up Stadium and Company Presentation forums offered at the Conference, announced FVCG President James M. Golubieski.
Key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis
Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.
Obesity epidemic in teens and young adults began to rise in late 1990s
A new study that looks at weight change over decades finds that the obesity epidemic in teens and young adults has its roots in the late 1990s and early 2000s, when body weights began to rise. But not everyone was affected equally.
Inlabtec introduces new dilution system for quantifying live probiotic bacteria
Inlabtec has introduced the TA12 Serial Diluter – a low cost, high productivity dilution system for reliably quantifying live probiotic bacteria.
YYM BioSciences prices underwritten public offering of 25,000,000 common shares
YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today announced that it has priced an underwritten public offering of 25,000,000 common shares at a price to the public of $1.60 per share.
› Verified 8 days ago